Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1720-8319
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms ; volume:28 ; number:5 ; day:27 ; month:11 ; year:2015 ; pages:843-851 ; date:10.2016
Aging clinical and experimental research ; 28, Heft 5 (27.11.2015), 843-851, 10.2016
- Creator
-
Gorska-Ciebiada, Malgorzata
- Contributor
-
Saryusz-Wolska, Malgorzata
Borkowska, Anna
Ciebiada, Maciej
Loba, Jerzy
SpringerLink (Online service)
- DOI
-
10.1007/s40520-015-0504-3
- URN
-
urn:nbn:de:1111-20161006868
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gorska-Ciebiada, Malgorzata
- Saryusz-Wolska, Malgorzata
- Borkowska, Anna
- Ciebiada, Maciej
- Loba, Jerzy
- SpringerLink (Online service)
Other Objects (12)
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
Urokinase-type plasminogen activator receptor in vascular calcification
Isolation and Properties of Human Vascular Plasminogen Activator
Influence of delivery on plasminogen activator inhibitor activity
Purification and Some Properties of Tissue Plasminogen Activator
Plasminogen Activator Release by Oral Contraceptives and Exercise
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
A Fibrinogen‐Mimicking, Activated‐Platelet‐Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
Urokinase-type plasminogen activator receptor in vascular calcification
Isolation and Properties of Human Vascular Plasminogen Activator
Influence of delivery on plasminogen activator inhibitor activity
Purification and Some Properties of Tissue Plasminogen Activator
Plasminogen Activator Release by Oral Contraceptives and Exercise
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
A Fibrinogen‐Mimicking, Activated‐Platelet‐Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
Urokinase-type plasminogen activator receptor in vascular calcification
Isolation and Properties of Human Vascular Plasminogen Activator
Influence of delivery on plasminogen activator inhibitor activity
Purification and Some Properties of Tissue Plasminogen Activator
Plasminogen Activator Release by Oral Contraceptives and Exercise
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers